With regard to anti-diabetic drugs, thiazolidinedione and Glucagon-like peptide-1 agonists were reported to have potential beneficial effects on psoriasis37, 38, whereas the use of insulin is associated with psoriasis development25. The gene discussed is GCG; the disease is psoriasis.